FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apotex Paxil CR Recall

Paxil CR, Paroxetine, Extended-Release Tablets, 37

Apotex Corp. · Weston, FL

Risk level
Class II
Reported by FDA
Sep 2, 2026
Recall ID
D-0804-2026
Check your lot numberHow we source this data

Summary

Apotex recalled Paxil CR starting Aug 13, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0804-2026 on Sep 2, 2026. Reason: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria

Product description

Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3

Lot numbers, UPCs & expiration codes

Lot # TY9494, Exp Date: 05/31/2027.

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0804-2026
Classification
Class II
Status
Ongoing
Recall initiated
Aug 13, 2026
FDA report date
Sep 2, 2026
Quantity
6,972 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-0804-2026, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Ongoing
Country
United States
Event ID
99673
Address
2400 N Commerce Pkwy Ste 400
Code information
Lot # TY9494, Exp Date: 05/31/2027.
Postal code
33326-3253
Report date
Sep 2, 2026
Product type
Drugs
Recall number
D-0804-2026
Classification
Class II
Recalling firm
Apotex Corp.
Product quantity
6,972 bottles
Reason for recall
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Voluntary / mandated
Voluntary: Firm initiated
Product description
Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3
Distribution pattern
US Nationwide.
Recall initiation date
Aug 13, 2026
Initial firm notification
Letter
Center classification date
Aug 27, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0804-2026, published Sep 2, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls